Brief: Cerevel Therapeutics announces pricing of $254 million public offering of common stock and concurrent $300 million private offering of convertible senior notes

Cerevel Therapeutics Holdings

12/08/2022 11:08

Aug 12 (Reuters) - Cerevel Therapeutics Holdings Inc
 CERE.O :
    * CEREVEL THERAPEUTICS ANNOUNCES PRICING OF $254 MILLION
PUBLIC
OFFERING OF COMMON STOCK AND CONCURRENT $300 MILLION PRIVATE
OFFERING OF CONVERTIBLE SENIOR NOTES
    * CEREVEL THERAPEUTICS - PRICING OF PREVIOUSLY ANNOUNCED
UNDERWRITTEN PUBLIC OFFERING OF 7,250,000 SHARES OF ITS COMMON
STOCK AT A $35.00 PER SHARE

Source text for Eikon:  ID:nGNX3gtJ8d 
Further company coverage:  CERE.O